Skip to content

Evaluation of CONOX, a new device, to measure ICU sedation

Correlation of qCON and Richmond Agitation Sedation Scale in Mechanically Ventilated Patients on Propofol-Fentanyl Sedation in the ICU: An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/020064
Enrollment
75
Registered
2019-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G978- Other intraoperative and postprocedural complications and disorders of nervous system Health Condition 2: J958- Other intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classified Health Condition 3: I978- Other intraoperative and postprocedural complications and disorders of the circulatory system, not elsewhere classified

Interventions

None listed

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who will be admitted to the ICU and receiving propofol sedation on mechanical ventilation will be included in the study.

Exclusion criteria

Exclusion criteria: 1. Patient care giver refusal or inability to give consent. 2. Patients on Neuromuscular Blocking drugs. 3. Patients being administered sedative drugs other than the prescribed regimens. 4. Patients having a history of stroke, coma, or head injury or any neurological impairment. 5. Patients with hypothermia (core temperature 6. Patients with haemodynamic instability(Mean BP 7. Patients with an APACHE II score of 15 or more on admission. 8. Patients with primary hyperlipidemia 9. Patients with pancreatitis 10. Patients with a Known allergy to eggs or propofol at the time of enrolment.

Design outcomes

Primary

MeasureTime frame
To assess correlation of qCON with clinical sedation score, Richmond Agitation Sedation Score (RASS).Timepoint: At the time of completion of study

Secondary

MeasureTime frame
The secondary outcome is to assess the ability of qCON to differentiate between inadequate, adequate and excessive sedation.Timepoint: At the time of completion of study

Countries

India

Contacts

Public ContactHarsha Makam

AIIMS Jodhpur

harshbuttrue142@gmail.com9949356787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 19, 2026